E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/27/2011 in the Prospect News Investment Grade Daily.

New Issue: Amgen prices $3 billion of five, 10-, 31-year senior notes

By Andrea Heisinger

New York, June 27 - Amgen Inc. sold $3 billion of senior notes (A3/A+/A-) on Monday in three tranches, said a source close to the sale.

The $750 million of 2.3% five-year notes priced at 99.768 to yield 2.35% with a spread of Treasuries plus 90 basis points. The notes were talked in the 95 bps area and priced at the low end of that guidance.

The notes have a make-whole call at Treasuries plus 15 bps.

A second tranche was $1 billion of 4.1% 10-year notes priced at 99.742 to yield 4.132% with a spread of 120 bps over Treasuries. The notes priced at the tight end of guidance in the 125 bps area.

The tranche is callable at a make-whole amount of Treasuries plus 20 bps.

The company also priced $1.25 billion of 5.65% notes due 2042 at 99.51 to yield 5.684% with a spread of Treasuries plus 140 bps. This tranche was sold at the tight end of talk in the 145 bps area.

The bonds have a make-whole call at Treasuries plus 25 bps.

All of the tranches had a plus or minus 5 bps margin on price guidance.

The notes feature a change-of-control put at 101%.

Bookrunners were Bank of America Merrill Lynch, Barclays Capital Inc. and Morgan Stanley & Co., Inc.

Proceeds are being used for general corporate purposes, including working capital, capital expenditures, debt service requirements and to repay outstanding debt, for common stock share repurchase, payment of quarterly stock dividends, and other business initiatives, including acquisitions and licensing activities.

The global biotechnology company is based in Thousand Oaks, Calif.

Issuer:Amgen Inc.
Issue:Senior notes
Amount:$3 billion
Bookrunners:Bank of America Merrill Lynch, Barclays Capital Inc., Morgan Stanley & Co., Inc.
Change-of-control put:101%
Trade date:June 27
Settlement date:June 30
Ratings:Moody's: A3
Standard & Poor's: A+
Fitch: A-
Five-year notes
Amount:$750 million
Maturity:June 15, 2016
Coupon:2.3%
Price:99.768
Yield:2.35%
Spread:Treasuries plus 90 bps
Call:Make-whole at Treasuries plus 15 bps
Price talk:95 bps area
10-year notes
Amount:$1 billion
Maturity:June 15, 2021
Coupon:4.1%
Price:99.742
Yield:4.132%
Spread:Treasuries plus 120 bps
Call:Make-whole at Treasuries plus 20 bps
Price talk:125 bps area
Notes due 2042
Amount:$1.25 billion
Maturity:June 15, 2042
Coupon:5.65%
Price:99.51
Yield:5.684%
Spread:Treasuries plus 140 bps
Call:Make-whole at Treasuries plus 25 bps
Price talk:145 bps area

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.